Dr José Nasser MD PHD Substack

Dr José Nasser MD PHD Substack

Share this post

Dr José Nasser MD PHD Substack
Dr José Nasser MD PHD Substack
Depoimento de IVERMECTINA & FENBENDAZOL - Paciente com câncer de pulmão estágio 4 de 60 anos tem resposta dramática com 37% de encolhimento do pulmão primário e 100% de encolhimento das metástases adr

Depoimento de IVERMECTINA & FENBENDAZOL …

Dr J Nasser MD and PHD
Jan 26
6

Share this post

Dr José Nasser MD PHD Substack
Dr José Nasser MD PHD Substack
Depoimento de IVERMECTINA & FENBENDAZOL - Paciente com câncer de pulmão estágio 4 de 60 anos tem resposta dramática com 37% de encolhimento do pulmão primário e 100% de encolhimento das metástases adr
3

This thread is only visible to paid subscribers of Dr José Nasser MD PHD Substack

Subscribe to view →

Keep reading with a 7-day free trial

Subscribe to Dr José Nasser MD PHD Substack to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 jose augusto nasser md phd
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share